Abstract:Spherical crystallization, a particle engineering technique, has been commonly used to modify the size and shape of particles to enhance the micromeritics properties of a powder and facilitate tablet formulation development. By identifying the key factors affecting the generation of spherical agglomerates and the underlying mechanism, spherical agglomerates with optimal size, shape and density can be obtained, presenting excellent flowability, tabletability and dissolution. The goals of this thesis work include: (i) prepare and evaluate the properties of the spherical agglomerates of drugs using the two main methods including spherical agglomeration (SA) and quasi-emulsion solvent diffusion (QESD) , (ii) explore high drug loading direct compression tablet formulations enabled by the spherical crystallization technique, (iii) develop a spherical cocrystallization technique to simultaneously improve the manufacturability and dissolution of drugs, and (iv) reduce the punch sticking propensity via a polymer assisted QESD method. To successfully prepare the spherical agglomerates, it is crucial to select a solvent system-based phase diagram. Spherical agglomerates of a model API, ferulic acid (FA), via a QESD process presented exceptional flowability and tabletability. Such spherical FA crystals enabled the development of a direct compression tablet formulation containing 99% of the API. Spherical griseofulvin agglomerates prepared by a SA process, exhibited not only good flowability but also excellent tabletability. The unexpected profoundly improved tabletability was attributed to a micro porous structure of primary crystals, due to an in-situ solvation and desolvation during the SA process, which enhanced the plasticity of the agglomerates. For low water-soluble drugs, spherical crystallization of more soluble cocrystals, i.e., spherical cocrystallization, is an enabling technology to simultaneously improve the manufacturability and dissolution and enable the development of high drug loading tablet formulation. Moreover, spherical agglomerates of celecoxib obtained via a polymer assisted QESD process not only showed substantially improved tabletability and flowability but also significantly reduced punch-sticking propensity. A thin layer of polymer coating onto the agglomerates surface, confirmed by SEM and XPS analysis, explains the reduced punch sticking propensity due to the physical barrier of polymer between the drug and punch.

Design and Preparation of Spherical Particles in Water Via Thermal-Induced Liquid-Liquid Phase Separation and a Molecular Mechanism Study

Production of Functional Spherical Particles with Porous Hollow Structures in Water Via Oiling-out Directional Agglomeration

Design of Spherical Crystallization for Drugs Based on Thermal-Induced Liquid–Liquid Phase Separation: Case Studies of Water-Insoluble Drugs

Improve the Manufacturability and Dissolution Performance of Drugs Through Spherical Crystallization

Design of Spherical Crystallization of Active Pharmaceutical Ingredients Via a Highly Efficient Strategy: from Screening to Preparation

Sustainable preparation of spherical particles of novel carbamazepine-hesperetin cocrystal via different crystallization strategies: From mechanism to application

Highly-Efficient Production Of Spherical Co-Agglomerates Of Drugs Via An Organic Solvent-Free Process And A Mechanism Study Dagger

Spherical agglomeration of high melting point drugs in water at low temperature by developing a two-step oiling-out mechanism and the design strategy

Design of Single and Multicomponent Drug Spherical Particles with Improved Powder Properties in Water Instead of Organic Solvents: A Case Study of Gemfibrozil

Design of Spherical Agglomerates Via Crystallization with a Non-Toxic Bridging Liquid: from Mechanism to Application

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

Particle Design of Drugs via Spherical Crystallization: A Review from Fundamental Aspects to Technology Development

Optimization of Green Spherical Agglomeration Process Based on Response Surface Methodology for Preparation of High-Performance Spherical Particles

Preparation of tenofovir amibufenamide fumarate spherical particles to improve tableting performance and sticking propensity by designing a spherical crystallization process

Preparation and Formation Mechanism of Spherical Particles with High Quality: A Case Study of L-Isoleucine

Design of Spherical Agglomeration Via Salt-Induced Liquid–liquid Phase Separation

Novel Environment-Friendly Spherical Agglomeration Process Designed by Crystal Self-Bridging Mechanism: A Case Study of Myo-Inositol

Fabrication of Micro Spherulitic Particles of Carbamazepine-Hesperetin Cocrystal Via QESD with Enhanced Manufacturability and Dissolution

Hollow And Solid Spherical Azithromycin Particles Prepared By Different Spherical Crystallization Technologies For Direct Tableting

Laser-induced reshaping of particles aiming at energy-saving applications

Sustainable Preparation of Spherical Amphoteric Organics:Isoelectric Point-Spherical Agglomeration Technology